Abstract
The rise of molecular biology and the imperatives of clinical practice have supported extensive research activity in antibiotic resistance. The terms have been developed taking into consideration the activity of the antibiotic and its pharmacokinetics. [...]a susceptible result should predict satisfactory therapy and a resistant result poor outcome. [...]the articles are related and highlight the difficulty of ensuring rational antibiotic usage, decrease emergence of resistance and controlling unnecessary cost to health care institutions.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Sir Dorabji Tata Centre for Research in Tropical Diseases, Innovation Centre, Indian Institute of Sciences Campus, Bangalore 560 029